Recommendations

106
Smith et al. 2005
ACC/AHA/SCAI Practice Guidelines
ACC - www.acc.org
AHA - www.americanheart.org
SCAI - www.scai.org
treatment of the past? Circulation 2003;107:2538-42.
417. Melandri G. The obsession with primary angioplasty. Circulation
2003;108:e162.
418. Berger PB, Ellis SG, Holmes DR, Jr., et al. Relationship between
delay in performing direct coronary angioplasty and early clinical
outcome in patients with acute myocardial infarction: results from
the global use of strategies to open occluded arteries in Acute
Coronary Syndromes (GUSTO-IIb) trial. Circulation 1999;100:
14-20.
419. Brodie BR, Stuckey TD, Hansen C, Muncy D. Benefit of coronary
reperfusion before intervention on outcomes after primary
angioplasty for acute myocardial infarction. Am J Cardiol
2000;85:13-8.
420. Stone GW, Cox D, Garcia E, et al. Normal flow (TIMI-3) before
mechanical reperfusion therapy is an independent determinant of
survival in acute myocardial infarction: analysis from the primary
angioplasty in myocardial infarction trials. Circulation
2001;104:636-41.
421. Nallamothu BK, Bates ER. Percutaneous coronary intervention
versus fibrinolytic therapy in acute myocardial infarction: is timing
(almost) everything? Am J Cardiol 2003;92:824-6.
422. Juliard JM, Feldman LJ, Golmard JL, et al. Relation of mortality
of primary angioplasty during acute myocardial infarction to
door-to-Thrombolysis In Myocardial Infarction (TIMI) time. Am
J Cardiol 2003;91:1401-5.
423. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute
myocardial infarction in patients presenting with ST-segment elevation.
The Task Force on the Management of Acute Myocardial
Infarction of the European Society of Cardiology. Eur Heart J
2003;24:28-66.
424. De LG, Suryapranata H, Ottervanger JP, Antman EM. Time delay
to treatment and mortality in primary angioplasty for acute
myocardial infarction: every minute of delay counts. Circulation
2004;109:1223-5.
425. Zijlstra F, van’t Hof AW, Liem AL, Hoorntje JC, Suryapranata H,
de Boer MJ. Transferring patients for primary angioplasty: a retrospective
analysis of 104 selected high risk patients with acute
myocardial infarction. Heart 1997;78:333-6.
426. Zahn R, Schiele R, Seidl K, et al. Primary Angioplasty in Acute
Myocardial Infarction: Differences Between Referred Patients
and Those Treated in Hospitals with On-site Facilities? J Invasive
Cardiol 1999;11:213-9.
427. Straumann E, Yoon S, Naegeli B, et al. Hospital transfer for primary
coronary angioplasty in high risk patients with acute
myocardial infarction. Heart 1999;82:415-9.
428. NRMI-4 Investigators. The National Registry of Myocardial
Infarction-4 Quarterly Report. 2003;2.
429. Nallamothu BK, Bates ER, Herrin J, Wang Y, Bradley EH,
Krumholz HM. Times to treatment in transfer patients undergoing
primary percutaneous coronary intervention in the United States:
National Registry of Myocardial Infarction (NRMI)-3/4 analysis.
Circulation 2005;111:761-7.
430. Kastrati A, Mehilli J, Dirschinger J, et al. Myocardial salvage
after coronary stenting plus abciximab versus fibrinolysis plus
abciximab in patients with acute myocardial infarction: a randomised
trial. Lancet 2002;359:920-5.
431. Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter
study of the safety and feasibility of primary stenting in acute
myocardial infarction:in-hospital and 30-day results of the PAMI
stent pilot trial. Primary Angioplasty in Myocardial Infarction
Stent Pilot Trial Investigators. J Am Coll Cardiol 1998;31:23-30.
432. Grines CL, Marsalese DL, Brodie B, et al. Safety and cost-effec-
tiveness of early discharge after primary angioplasty in low-risk
patients with acute myocardial infarction. PAM-II Investigators.
Primary Angioplasty in Myocardial Infarction. J Am Coll Cardiol
1998;31:967-72.
433. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with
or without stent implantation for acute myocardial infarction.
Stent Primary Angioplasty in Myocardial Infarction Study Group.
N Engl J Med 1999;341:1949-56.
434. Antoniucci D, Santoro GM, Bolognese L, Valenti R, Trapani M,
Fazzini PF. A clinical trial comparing primary stenting of the
infarct-related artery with optimal primary angioplasty for acute
myocardial infarction: results from the Florence Randomized
Elective Stenting in Acute Coronary Occlusions (FRESCO) trial.
J Am Coll Cardiol 1998;31:1234-9.
435. Maillard L, Hamon M, Khalife K, et al. A comparison of systematic
stenting and conventional balloon angioplasty during primary
percutaneous transluminal coronary angioplasty for acute
myocardial infarction. STENTIM-2 Investigators. J Am Coll
Cardiol 2000;35:1729-36.
436. Saito S, Hosokawa G, Tanaka S, Nakamura S. Primary stent
implantation is superior to balloon angioplasty in acute myocardial
infarction: final results of the primary angioplasty versus
stent implantation in acute myocardial infarction (PASTA) trial.
PASTA Trial Investigators. Catheter Cardiovasc Interv 1999;48:
262-8.
437. Scheller B, Hennen B, Severin-Kneib S, Ozbek C, Schieffer H,
Markwirth T. Long-term follow-up of a randomized study of primary
stenting versus angioplasty in acute myocardial infarction.
Am J Med 2001;110:1-6.
438. Rodriguez A, Bernardi V, Fernandez M, et al. In-hospital and late
results of coronary stents versus conventional balloon angioplasty
in acute myocardial infarction (GRAMI trial). Gianturco-
Roubin in Acute Myocardial Infarction. Am J Cardiol
1998;81:1286-91.
439. Suryapranata H, Ottervanger JP, Nibbering E, et al. Long term
outcome and cost-effectiveness of stenting versus balloon angioplasty
for acute myocardial infarction. Heart 2001;85:667-71.
440. Zhu MM, Feit A, Chadow H, Alam M, Kwan T, Clark LT.
Primary stent implantation compared with primary balloon angioplasty
for acute myocardial infarction: a meta-analysis of randomized
clinical trials. Am J Cardiol 2001;88:297-301.
441. Lemos PA, Saia F, Hofma SH, et al. Short- and long-term clinical
benefit of sirolimus-eluting stents compared to conventional bare
stents for patients with acute myocardial infarction. J Am Coll
Cardiol 2004;43:704-8.
442. Montalescot G, Barragan P, Wittenberg O, et al. Platelet glycoprotein
IIb/IIIa inhibition with coronary stenting for acute
myocardial infarction. N Engl J Med 2001;344:1895-903.
443. Brener SJ, Barr LA, Burchenal JE, et al. Randomized, placebocontrolled
trial of platelet glycoprotein IIb/IIIa blockade with primary
angioplasty for acute myocardial infarction. ReoPro and
Primary PTCA Organization and Randomized Trial (RAPPORT)
Investigators. Circulation 1998;98:734-41.
444. Montalescot G. Glycoprotein IIb/IIIa inhibition and long-term
benefit: the stuff of dreams? Eur Heart J 2004;25:1562-4.
445. Stellbrink C, Nixdorff U, Hofmann T, et al. Safety and efficacy of
enoxaparin compared with unfractionated heparin and oral anticoagulants
for prevention of thromboembolic complications in
cardioversion of nonvalvular atrial fibrillation: the
Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
Circulation 2004;109:997-1003.
446. Topol EJ, Neumann FJ, Montalescot G. A preferred reperfusion